Results 131 to 140 of about 13,031,604 (304)

Production of antibody to hepatitis B using only antibodies that are directed against anti-hepatitis B antibodies

Gastroenterology, 1984
R.C. Kennedy, G.R. Dreesman
openaire   +2 more sources

Seroprevalence of hepatitis B, C, and its associated risk factors among clinically suspected patients attending poly and Maraki Health Centers, Gondar City, North West Ethiopia

SAGE Open Medicine
Background: Hepatitis B and C viruses are major global health problems with a high mortality rate, mostly due to serious liver diseases such as liver cirrhosis, liver failure, and hepatocellular carcinoma. The objective of this study was to determine the
Solomon Tesfaye, Adefework Alemu, Endalkachew Bizualem, Daniel Mehabie, Amir Alelign   +4 more
doaj   +1 more source

Integrated Clinical and Proteomic Profiling of CD19 Chimeric Antigen Receptor T Cell Therapy in Progressive Systemic Sclerosis

Arthritis &Rheumatology, EarlyView.
Objective To characterize the clinical, immunologic, and proteomic changes associated with CD19 chimeric antigen receptor T cell therapy in patients with progressive systemic sclerosis (SSc). Methods Patients with progressive SSc received CD19 chimeric antigen receptor (CAR)‐T cell therapy and were observed longitudinally for safety, clinical efficacy,
Chenhan Jia, Wanyi Lin, Zhangyi Zhao, Fenglin Wu, Chaoyu Gu, Yuankai Sun, Zhe Ding, Chang Wei, Xinyu Li, Cuiwei Xie, Peng Xia, Zhen Xia, Xuesong Liu, Shaoying Yang, Chunyan Zhang, Hanlin Yin, Liangjing Lu   +16 more
wiley   +1 more source

PERCENTAGE OF HEPATITIS B AND C AMONG YOUNG ADULT MALES FROM INTERIOR SINDH

Pakistan Armed Forces Medical Journal, 2008
Objective: Present study was planned to know the seropercentage of Hepatitis C Antibodies and Hepatitis B Surface Antigen in a population based sample of healthy male army/naval recruits from rural Sindh.
Nasrullah Malik, Tariq Butt, M. Nasir Mansoor, Tahir Ghias Khan, Muhammad Sajid Akbar, Muhammad Aslam   +5 more
doaj   +2 more sources

Hepatitis B: Are You At Risk? (Vietnamese)

Read the hepatitis B fact sheet in ...

core   +1 more source

Hepatitis B: Are You At Risk? (Chinese)

Learn more about information for people at risk for hepatitis B ...

core   +2 more sources

From Interferon Signature to the Clinical Landscape: Type I Interferonopathies

Arthritis &Rheumatology, EarlyView.
Objective TypeI interferonopathies are heterogeneous diseases driven by dysregulated type I interferon (IFN‐I) signaling. Diagnosis is challenging due to clinical/molecular variability and the need for IFN‐I quantification. The aim of this study was to characterize the clinical, immunologic, genetic, molecular profiles of patients with suspected ...
Ismail Yaz, Seza Ozen, Hacer Neslihan Bildik, Canberk Ipsir, Dilara Unal, Saliha Esenboga, Begum Cicek, Mehmet Emin Seker, Fatima Aerts‐Kaya, Seher Sener, Mehmet Orhan Erkan, Hanife Avci, Deniz Cagdas, Ilhan Tezcan   +13 more
wiley   +1 more source

Hepatitis B: Are You At Risk? (Khmer)

Read the hepatitis B fact sheet in ...

core   +1 more source

Purification of Disassembled Capsid Protein by Hydroxyapatite Chromatography Enhances Virus‐Like Particle Recovery

Biotechnology and Bioengineering, EarlyView.
ABSTRACT Virus‐like particles (VLPs) are a promising modality with extensive applications in prophylactic and therapeutic vaccine design. Human Papillomavirus (HPV) vaccines are one such example where VLP vaccine applications have led to the successful reduction in HPV‐associated diseases, such as cervical cancer.
Nicholas Samuelson, Nathaniel Parker, Shiyi Wang, Sara Daley, Aaron Cote, Michael A. Winters   +5 more
wiley   +1 more source

Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV):use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3 [PDF]

, 1993
The effect of sequence variability between different types of hepatitis C virus (HCV) on the antigenicity of the NS-4 protein was investigated by epitope mapping and by enzyme-linked immunosorbent assay with branched oligopeptides. Epitope mapping of the
Graham, S., Dow, B. C., Marsden, H, Chan, S. W., Rose, K A, Dow, B C, Follett, E. A C, McOmish, F, Yap, P. L., McOmish, F., Chan, S W, Rose, K. A., Follett, E A, Marsden, H., Simmonds, P., Simmonds, P, Graham, S, Yap, P L   +17 more
core